Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Russian Cancer Research Center N.N. Blokhin

2 abstracts

Abstract
Defendor special: Interim analysis of TCHP with primary empegfilgrastim prophylaxis (long-acting G-CSF) for treatment outcomes in early HER2+ breast cancer.
Org: Moscow Clinical Scientific Center named after A.S. Loginov, Russian Cancer Research Center N.N. Blokhin,
Abstract
The polymorphic markers of the XRCC1, ERCC5, TP53, CDKN1A1 genes and the survival of triple negative breast cancer patients after platinum-based chemotherapy.
Org: Russian Medical Academy of Continuous Professional Education, Emanuel Institute of Biochemical Physics, Federal Research & Clinical Center of Physical-Chemical Medicine FMBA of Russia, Russian Cancer Research Center N.N. Blokhin, B.I. Kulakov Research National Center of Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation,